State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Prostate (Late Stage^), 2017-2021

All Races (includes Hispanic), Male, All Ages

Sorted by CI*Rank

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 24.7 with a 95% confidence interval from 24.6 to 24.8 and 48,295 average annual cases over 2017-2021.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage : 21.5

District of Columbia⁶

• Rate : The incidence rate is 32.0 with a 95% confidence interval from 29.1 to 35.0 and 96 average annual cases over 2017-2021.
• CI*Rank ⋔ : 1 (1, 15)
• Percent of Cases with Late Stage : 22.9

Vermont⁶

• Rate : The incidence rate is 31.8 with a 95% confidence interval from 29.5 to 34.3 and 150 average annual cases over 2017-2021.
• CI*Rank ⋔ : 2 (1, 13)
• Percent of Cases with Late Stage : 28.8

Minnesota⁶

• Rate : The incidence rate is 31.7 with a 95% confidence interval from 30.8 to 32.5 and 1,113 average annual cases over 2017-2021.
• CI*Rank ⋔ : 3 (1, 6)
• Percent of Cases with Late Stage : 26.5

Wisconsin⁶

• Rate : The incidence rate is 31.1 with a 95% confidence interval from 30.3 to 31.9 and 1,199 average annual cases over 2017-2021.
• CI*Rank ⋔ : 4 (1, 7)
• Percent of Cases with Late Stage : 24.6

North Dakota⁶

• Rate : The incidence rate is 30.7 with a 95% confidence interval from 28.4 to 33.1 and 142 average annual cases over 2017-2021.
• CI*Rank ⋔ : 5 (1, 16)
• Percent of Cases with Late Stage : 24.8

Iowa³

• Rate : The incidence rate is 30.3 with a 95% confidence interval from 29.3 to 31.5 and 621 average annual cases over 2017-2021.
• CI*Rank ⋔ : 6 (1, 11)
• Percent of Cases with Late Stage : 23.9

Montana⁶

• Rate : The incidence rate is 29.2 with a 95% confidence interval from 27.5 to 31.0 and 229 average annual cases over 2017-2021.
• CI*Rank ⋔ : 7 (2, 19)
• Percent of Cases with Late Stage : 21.7

Connecticut³

• Rate : The incidence rate is 29.1 with a 95% confidence interval from 28.1 to 30.1 and 669 average annual cases over 2017-2021.
• CI*Rank ⋔ : 8 (4, 16)
• Percent of Cases with Late Stage : 21.8

Nebraska⁶

• Rate : The incidence rate is 29.1 with a 95% confidence interval from 27.7 to 30.5 and 347 average annual cases over 2017-2021.
• CI*Rank ⋔ : 9 (3, 17)
• Percent of Cases with Late Stage : 23.9

Louisiana³

• Rate : The incidence rate is 29.1 with a 95% confidence interval from 28.1 to 30.0 and 817 average annual cases over 2017-2021.
• CI*Rank ⋔ : 10 (5, 16)
• Percent of Cases with Late Stage : 20.6

Washington⁵

• Rate : The incidence rate is 28.7 with a 95% confidence interval from 28.0 to 29.5 and 1,288 average annual cases over 2017-2021.
• CI*Rank ⋔ : 11 (6, 16)
• Percent of Cases with Late Stage : 26.7

South Dakota⁶

• Rate : The incidence rate is 28.5 with a 95% confidence interval from 26.5 to 30.6 and 161 average annual cases over 2017-2021.
• CI*Rank ⋔ : 12 (2, 25)
• Percent of Cases with Late Stage : 22.4

Illinois³

• Rate : The incidence rate is 28.1 with a 95% confidence interval from 27.5 to 28.6 and 2,150 average annual cases over 2017-2021.
• CI*Rank ⋔ : 13 (9, 17)
• Percent of Cases with Late Stage : 23.6

Massachusetts³

• Rate : The incidence rate is 27.9 with a 95% confidence interval from 27.2 to 28.6 and 1,216 average annual cases over 2017-2021.
• CI*Rank ⋔ : 14 (8, 18)
• Percent of Cases with Late Stage : 24.2

New Hampshire⁶

• Rate : The incidence rate is 27.9 with a 95% confidence interval from 26.3 to 29.4 and 272 average annual cases over 2017-2021.
• CI*Rank ⋔ : 15 (6, 24)
• Percent of Cases with Late Stage : 23.1

Idaho³

• Rate : The incidence rate is 27.7 with a 95% confidence interval from 26.3 to 29.2 and 304 average annual cases over 2017-2021.
• CI*Rank ⋔ : 16 (6, 24)
• Percent of Cases with Late Stage : 22.5

Hawaii³

• Rate : The incidence rate is 27.3 with a 95% confidence interval from 25.8 to 28.8 and 268 average annual cases over 2017-2021.
• CI*Rank ⋔ : 17 (7, 28)
• Percent of Cases with Late Stage : 26.7

New York³

• Rate : The incidence rate is 26.9 with a 95% confidence interval from 26.4 to 27.3 and 3,275 average annual cases over 2017-2021.
• CI*Rank ⋔ : 18 (15, 21)
• Percent of Cases with Late Stage : 20.1

Mississippi⁶

• Rate : The incidence rate is 26.2 with a 95% confidence interval from 25.2 to 27.4 and 467 average annual cases over 2017-2021.
• CI*Rank ⋔ : 19 (14, 30)
• Percent of Cases with Late Stage : 19.3

Oregon⁶

• Rate : The incidence rate is 26.2 with a 95% confidence interval from 25.3 to 27.1 and 723 average annual cases over 2017-2021.
• CI*Rank ⋔ : 20 (15, 29)
• Percent of Cases with Late Stage : 26.3

Maine⁶

• Rate : The incidence rate is 25.9 with a 95% confidence interval from 24.5 to 27.4 and 270 average annual cases over 2017-2021.
• CI*Rank ⋔ : 21 (13, 32)
• Percent of Cases with Late Stage : 24.1

Colorado⁶

• Rate : The incidence rate is 25.8 with a 95% confidence interval from 25.0 to 26.7 and 814 average annual cases over 2017-2021.
• CI*Rank ⋔ : 22 (16, 30)
• Percent of Cases with Late Stage : 24.8

Ohio⁶

• Rate : The incidence rate is 25.8 with a 95% confidence interval from 25.2 to 26.3 and 1,954 average annual cases over 2017-2021.
• CI*Rank ⋔ : 23 (18, 29)
• Percent of Cases with Late Stage : 21.6

North Carolina⁶

• Rate : The incidence rate is 25.7 with a 95% confidence interval from 25.1 to 26.3 and 1,591 average annual cases over 2017-2021.
• CI*Rank ⋔ : 24 (18, 30)
• Percent of Cases with Late Stage : 19.3

Utah³

• Rate : The incidence rate is 25.4 with a 95% confidence interval from 24.2 to 26.7 and 364 average annual cases over 2017-2021.
• CI*Rank ⋔ : 25 (16, 33)
• Percent of Cases with Late Stage : 20.5

Georgia³

• Rate : The incidence rate is 25.3 with a 95% confidence interval from 24.7 to 25.9 and 1,451 average annual cases over 2017-2021.
• CI*Rank ⋔ : 26 (19, 31)
• Percent of Cases with Late Stage : 17.9

Pennsylvania⁶

• Rate : The incidence rate is 25.3 with a 95% confidence interval from 24.8 to 25.8 and 2,213 average annual cases over 2017-2021.
• CI*Rank ⋔ : 27 (20, 31)
• Percent of Cases with Late Stage : 22.8

California³

• Rate : The incidence rate is 25.3 with a 95% confidence interval from 25.0 to 25.6 and 5,488 average annual cases over 2017-2021.
• CI*Rank ⋔ : 28 (22, 30)
• Percent of Cases with Late Stage : 25.3

Rhode Island⁶

• Rate : The incidence rate is 25.3 with a 95% confidence interval from 23.6 to 27.0 and 178 average annual cases over 2017-2021.
• CI*Rank ⋔ : 29 (14, 37)
• Percent of Cases with Late Stage : 21.8

Michigan⁶

• Rate : The incidence rate is 24.7 with a 95% confidence interval from 24.1 to 25.2 and 1,634 average annual cases over 2017-2021.
• CI*Rank ⋔ : 30 (24, 33)
• Percent of Cases with Late Stage : 21.3

New Jersey³

• Rate : The incidence rate is 24.0 with a 95% confidence interval from 23.4 to 24.6 and 1,358 average annual cases over 2017-2021.
• CI*Rank ⋔ : 31 (28, 36)
• Percent of Cases with Late Stage : 16.7

Delaware⁶

• Rate : The incidence rate is 23.8 with a 95% confidence interval from 22.1 to 25.6 and 158 average annual cases over 2017-2021.
• CI*Rank ⋔ : 32 (19, 42)
• Percent of Cases with Late Stage : 17.5

Missouri⁶

• Rate : The incidence rate is 23.5 with a 95% confidence interval from 22.8 to 24.2 and 923 average annual cases over 2017-2021.
• CI*Rank ⋔ : 33 (30, 39)
• Percent of Cases with Late Stage : 24.1

Maryland⁶

• Rate : The incidence rate is 23.3 with a 95% confidence interval from 22.6 to 24.1 and 849 average annual cases over 2017-2021.
• CI*Rank ⋔ : 34 (30, 41)
• Percent of Cases with Late Stage : 16.8

Tennessee⁶

• Rate : The incidence rate is 23.0 with a 95% confidence interval from 22.3 to 23.7 and 980 average annual cases over 2017-2021.
• CI*Rank ⋔ : 35 (31, 41)
• Percent of Cases with Late Stage : 19.9

Kentucky³

• Rate : The incidence rate is 22.9 with a 95% confidence interval from 22.1 to 23.8 and 624 average annual cases over 2017-2021.
• CI*Rank ⋔ : 36 (31, 42)
• Percent of Cases with Late Stage : 19.4

Alaska⁶

• Rate : The incidence rate is 22.8 with a 95% confidence interval from 20.5 to 25.3 and 87 average annual cases over 2017-2021.
• CI*Rank ⋔ : 37 (19, 46)
• Percent of Cases with Late Stage : 21.0

South Carolina⁶

• Rate : The incidence rate is 22.6 with a 95% confidence interval from 21.9 to 23.4 and 749 average annual cases over 2017-2021.
• CI*Rank ⋔ : 38 (32, 42)
• Percent of Cases with Late Stage : 19.9

Texas³

• Rate : The incidence rate is 22.6 with a 95% confidence interval from 22.2 to 22.9 and 3,251 average annual cases over 2017-2021.
• CI*Rank ⋔ : 39 (34, 42)
• Percent of Cases with Late Stage : 20.8

Virginia⁶

• Rate : The incidence rate is 22.3 with a 95% confidence interval from 21.7 to 22.9 and 1,125 average annual cases over 2017-2021.
• CI*Rank ⋔ : 40 (34, 42)
• Percent of Cases with Late Stage : 20.2

Kansas⁶

• Rate : The incidence rate is 22.2 with a 95% confidence interval from 21.3 to 23.3 and 397 average annual cases over 2017-2021.
• CI*Rank ⋔ : 41 (32, 44)
• Percent of Cases with Late Stage : 18.4

Wyoming⁶

• Rate : The incidence rate is 21.3 with a 95% confidence interval from 19.2 to 23.5 and 84 average annual cases over 2017-2021.
• CI*Rank ⋔ : 42 (30, 50)
• Percent of Cases with Late Stage : 18.2

Florida⁶

• Rate : The incidence rate is 21.1 with a 95% confidence interval from 20.7 to 21.4 and 3,238 average annual cases over 2017-2021.
• CI*Rank ⋔ : 43 (41, 44)
• Percent of Cases with Late Stage : 20.3

Oklahoma⁶

• Rate : The incidence rate is 20.5 with a 95% confidence interval from 19.7 to 21.3 and 480 average annual cases over 2017-2021.
• CI*Rank ⋔ : 44 (41, 47)
• Percent of Cases with Late Stage : 19.7

West Virginia⁶

• Rate : The incidence rate is 19.7 with a 95% confidence interval from 18.6 to 20.9 and 253 average annual cases over 2017-2021.
• CI*Rank ⋔ : 45 (42, 50)
• Percent of Cases with Late Stage : 18.9

New Mexico³

• Rate : The incidence rate is 19.4 with a 95% confidence interval from 18.4 to 20.5 and 268 average annual cases over 2017-2021.
• CI*Rank ⋔ : 46 (43, 50)
• Percent of Cases with Late Stage : 22.2

Arkansas⁶

• Rate : The incidence rate is 19.0 with a 95% confidence interval from 18.1 to 20.0 and 358 average annual cases over 2017-2021.
• CI*Rank ⋔ : 47 (44, 50)
• Percent of Cases with Late Stage : 18.3

Arizona⁶

• Rate : The incidence rate is 19.0 with a 95% confidence interval from 18.4 to 19.6 and 865 average annual cases over 2017-2021.
• CI*Rank ⋔ : 48 (44, 50)
• Percent of Cases with Late Stage : 23.6

Alabama⁶

• Rate : The incidence rate is 18.2 with a 95% confidence interval from 17.6 to 18.9 and 582 average annual cases over 2017-2021.
• CI*Rank ⋔ : 49 (46, 50)
• Percent of Cases with Late Stage : 15.8

Nevada⁶

• Rate : The incidence rate is 18.1 with a 95% confidence interval from 17.3 to 19.1 and 341 average annual cases over 2017-2021.
• CI*Rank ⋔ : 50 (45, 50)
• Percent of Cases with Late Stage : 18.8

Puerto Rico⁶

• Rate : The incidence rate is 14.8 with a 95% confidence interval from 14.0 to 15.5 and 303 average annual cases over 2017-2021.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage : 10.4

Indiana⁶

• Rate : Data not available for this combination of data selections.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage : data not available

Notes:
Created by statecancerprofiles.cancer.gov on 07/13/2025 2:48 am.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.
¹ Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
³ Source: SEER November 2023 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
⁵ Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
⁶ Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2023 submission).

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.